Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
97,734,732
-
Total 13F shares
-
12,442,068
-
Share change
-
+2,220,402
-
Total reported value
-
$101,778,750
-
Price per share
-
$8.18
-
Number of holders
-
44
-
Value change
-
+$17,956,768
-
Number of buys
-
25
-
Number of sells
-
19
Institutional Holders of Oric Pharmaceuticals, Inc. - Common Stock (ORIC) as of Q4 2025
As of 31 Dec 2025,
Oric Pharmaceuticals, Inc. - Common Stock (ORIC) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,442,068 shares.
The largest 10 holders included
VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, ROYCE & ASSOCIATES LP, UBS Group AG, Blue Owl Capital Holdings LP, Connor, Clark & Lunn Investment Management Ltd., Bank of New York Mellon Corp, Hennion & Walsh Asset Management, Inc., and TD Asset Management Inc.
This page lists
44
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.